OSI Pharmaceuticals Overview

  • Founded
  • 1983

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 557

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 4

OSI Pharmaceuticals General Information

Description

Manufacturer and seller of cancer medicines. The company engages in discovering, developing and commercialization of molecular targeted therapies used in oncology, diabetes and obesity disease. It also manufactures and sells cancer medicine Tarceva.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 41 Pinelawn Road
  • Melville, NY 11747
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OSI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OSI Pharmaceuticals‘s full profile, request access.

Request a free trial

OSI Pharmaceuticals Patents

OSI Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170273982-A1 Pulse dosing regimen and methods of treatment Granted 25-Mar-2016 000000000
US-20220133725-A1 Pulse dosing regimen and methods of treatment Pending 25-Mar-2016 0000000000
US-10583142-B2 Pulse dosing regimen and methods of treatment Active 25-Mar-2016 000000000
US-11253520-B2 Pulse dosing regimen and methods of treatment Active 25-Mar-2016 000000000
US-20200230142-A1 Pulse dosing regimen and methods of treatment Granted 25-Mar-2016 A61K31/517
To view OSI Pharmaceuticals’s complete patent history, request access »

OSI Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Neil Gibson Ph.D Chief Scientific Officer
You’re viewing 1 of 4 executive team members. Get the full list »

OSI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OSI Pharmaceuticals Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 25-Jun-2009 00000 0000 0000 Biotechnology
0000000 00000 14-Nov-2005 0000000000 00000 Pharmaceuticals
0000 00000000 12-Jun-2003 0000000000 0000 Biotechnology
Gilead Sciences (Oncology Assets) 26-Nov-2001 Corporate Asset Purchase 00000 Buildings and Property 00000 000
To view OSI Pharmaceuticals’s complete investments and acquisitions history, request access »

OSI Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000000 25-Jun-2009 00000 00000 00 0000 Completed
  • 000 00000000000000
Eyetech Pharmaceuticals 14-Nov-2005 Merger/Acquisition 00000 Completed
To view OSI Pharmaceuticals’s complete exits history, request access »